|会社名||Endeavour Silver Corp （ENDEAVOUR SILVR）|
|概要||エンデバー・シルバー（Endeavour Silver Corp.）はメキシコで銀採掘物件の評価・買収・探査・開発・開拓に従事するほか、チリで探査に従事する。同社の生産鉱山はグアナセビ鉱山、ボラニトス鉱山とエルクーボを含む。グアナセビ鉱山プロジェクトとボラニトス鉱山プロジェクトは事業活動の主要な焦点とする。エルクーボは中央メキシコの歴史的グアナフアト鉱山地区の南東部にある産銀・金鉱山であり、グアナフアト地区の北西部にある同社の運営ボラニトス銀・金鉱山からただ10キロに位置する。平成24年7月13日、同社はAuRico Gold Inc. （AuRico）からMexgold Resources Inc.（Mexgold）及びCompania Minera del Cubo S.A. de C.V.、AuRico Gold GYC S.A. de C.V.とMetales Interamericanos S.A. de C.V.という完全子会社3社に対する買収を完了した。 エンデバ―・シルバ―は、カナダの銀生産会社。子会社を通じ、メキシコの鉱山を評価、取得、探鉱、開発し、銀や金を搾取する。メキシコの採掘作業中の鉱山には、ドゥランゴ州のグアナセビおよびグアナファト州のボラニトスとエル・クボがあり、地下鉱山からの銀・金を生産する。バンク―バ―に本社を置く。|
|本社所在地||Suite 1130 609 Granville Street Vancouver British Columbia V7Y 1G5 CAN|
|代表者氏名||Geoffery Arthur Handley|
|代表者役職名||Independent Chairman of the Board|
|決算概要||BRIEF: For the fiscal year ended 31 December 2018 Endeavour Silver Corp revenues remained flat at $150.5M. Net loss totaled $12.4M vs. income of $9.7M. Revenues reflect El Cubo segment increase of 22% to $71.5M also reflect Bolanitos segment decrease of 18% to $39.8M Guanacevi segment decrease of 10% to $39.2M. Net loss reflects Salaries wages and benefits increase of 36% to $3M (expense).|
Exact Sciences to participate in March investor conferences 2021/02/22 11:00:00 PR Newswire Media
MADISON, Wis., Feb. 22, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following virtual conferences and invited investors to participate by webcast. Cowen 41st Annual Health Care Conference Fireside Chat on…
Exact Sciences Drops on Earnings Loss, Lack of Visibility 2021/02/17 18:00:28 The Street
Exact Sciences swung to a large fourth quarter loss due in part to its purchase of Base Genomics.
Exact Sciences Announces Fourth Quarter 2020 Results 2021/02/16 21:05:00 PR Newswire
MADISON, Wis., Feb. 16, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $466.3 million for the fourth quarter ended Dec. 31, 2020 and $1,491.4 million for the full year ended Dec. 31, 2020. "Exact Sciences finished another…
A Preview Of Exact Sciences's Earnings 2021/02/15 10:34:00 Benzinga
Exact Sciences (NASDAQ:EXAS) announces its next round of earnings this Tuesday, February 16. Here is Benzinga's look at Exact Sciences's Q4 earnings …
Exact Sciences prepares to open Rochester site in One Discovery Square | Post Bulletin 2021/02/11 02:01:21 Post Bulletin
Wisconsin-based Exact Sciences, which makes the colorectal cancer test called Cologuard, has filed building permits for a new Rochester site on the second floor of One Discovery Square, 202 Fourth St. SW.
Cologuard accurately screens younger individuals for colorectal cancer 2021/01/15 18:00:00 BioWorld
The U.S. Preventive Services Task Force (USPSTF) appears on the verge of expanding colorectal cancer screening to individuals ages 45 to 49, based on its latest draft recommendations. If it does, Exact Sciences Corp. is ready. A study in Cancer Prevention Research demonstrated that the Madison, Wis.-based company's Cologuard multitarget stool DNA test had better than 95% specificity in individuals with nonadvanced precancerous lesions or negative findings on colonoscopy.
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations 2021/01/13 12:25:38 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) AbbVie Inc (NYSE: ABBV ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alkermes Plc (NASDAQ: ALKS ) AtriCure Inc. (NASDAQ: ATRC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) BIOLASE Inc (NASDAQ: BIOL ) (announced an agreement to expand laser adoption and hands-on training programs in targeted geographies) CareDx Inc (NASDAQ: CDNA ) Celsius Holdings, Inc. (NASDAQ: CELH ) DermTech Inc (NASDAQ: DMTK ) Dyne Therapeutics Inc (NASDAQ: DYN ) Edap Tms SA (NASDAQ: EDAP ) Evelo Biosciences Inc (NASDAQ: EVLO ) EXACT Sciences Corporation (NASDAQ: EXAS ) Eyenovia Inc (NASDAQ: EYEN ) Genetron Holdings Ltd – ADR (NASDAQ: GTH ) Guardant Health Inc (NASDAQ: GH ) (reacted to presentation at the JPMorgan Healthcare Conference) Intra-Cellular Therapies Inc (NASDAQ: ITCI ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Laboratory Corp.
New Prospective Data Demonstrate Low False-Positive Rate for Screening Average-Risk People Age 45-49 for Colorectal Cancer with Cologuard® 2021/01/12 19:45:00 PR Newswire
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) announced data published today in Cancer Prevention Research, a Journal of the American Association for…
Should you invest in Exxon Mobil, Wells Fargo, General Motors, Etsy, or EXACT Sciences? 2021/01/12 15:55:00 Benzinga
NEW YORK , Jan. 12, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for XOM, WFC, GM, ETSY, and EXAS. … Full story available on Benzinga.com
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue 2021/01/12 13:15:54 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 11) 10X Genomics Inc (NASDAQ: TXG ) AbbVie Inc (NYSE: (ABBV) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) (reacted to the company's preliminary fourth-quarter results) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Biodesix Inc (NASDAQ: BDSX ) C4 Therapeutics Inc (NASDAQ: CCCC ) CareDx Inc (NASDAQ: CDNA ) (announced preliminary fourth-quarter results) Celsius Holdings, Inc. (NASDAQ: CELH ) Chimerix Inc (NASDAQ: CMRX ) Curis, Inc. (NASDAQ: CRIS ) Dyne Therapeutics Inc (NASDAQ: DYN ) (announced positive preclinical data from its myotonic dystrophy type 1 program) Edap Tms SA (NASDAQ: EDAP ) Eli Lilly And Co (NYSE: LLY ) (announced positive data from midphase study of its investigational asset in treating early symptomatic Alzheimer's) ESSA Pharma Inc (NASDAQ: EPIX ) EXACT Sciences Corporation (NASDAQ: EXAS ) (reacted to preliminary fourth-quarter results) Eyenovia Inc (NASDAQ: EYEN ) Guardant Health Inc (NASDAQ: GH ) Johnson & Johnson (NYSE: JNJ ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Oxford Immunotec Global PLC (NASDAQ: OXFD ) Pacira Biosciences Inc (NASDAQ: PCRX ) Supernus Pharmaceuticals Inc (NASDAQ: SUPN ) Syneos Health Inc (NASDAQ: SYNH ) Theratechnologies Inc (NASDAQ: THTX ) Twist Bioscience Corp (NASDAQ: TWST ) United Therapeutics Corporation (NASDAQ: UTHR ) Vascular Biogenics Ltd (NASDAQ: VBLT ) Xencor Inc (NASDAQ: XNCR ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Jan.
Why Exact Sciences Stock Is Trading Higher Today 2020/09/24 12:11:00 Benzinga
Exact Sciences (NASDAQ: EXAS) shares are trading higher on Thursday after the company’s CEO Kevin Conroy presenting at Cowen's Liquid Biopsy …
Exact Sciences to participate in Cowen Liquid Biopsy Summit 2020/09/17 10:00:00 PR Newswire
MADISON, Wis., Sept. 17, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following event and invited investors to participate by webcast. Cowen Liquid Biopsy Summit Presentation on Thursday, September 24, 2020, at…
Exact Sciences (EXAS) Investor Presentation - Slideshow (NASDAQ:EXAS) 2020/09/10 18:34:17 Seeking Alpha
The following slide deck was published by Exact Sciences Corporation in conjunction with this event.
Exact Sciences to participate in September investor conference 2020/09/01 20:10:00 PR Newswire
MADISON, Wis., Sept. 1, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conference and invited investors to participate by webcast. Baird Global Healthcare Conference Fireside Chat on Wednesday, September…
関連キーワード （貴金属_鉱物 米国株 ENDEAVOUR SILVR EXK ）